.claude/skills/target-drug-bd-assessmentRuntime, accounts, dependencies, permissions, network behavior and task quality remain untested.
整合靶点证据、药物管线、专利与交易开展BD评估
These states come from the source or distribution context. None of the entries below are SkillVetAI compatibility test results.
These checks parse the fixed package against dated platform rules. They do not execute the Skill or verify task behavior.
.claude/skills/target-drug-bd-assessmentRuntime, accounts, dependencies, permissions, network behavior and task quality remain untested.
.agents/skills/target-drug-bd-assessmentRuntime, accounts, dependencies, permissions, network behavior and task quality remain untested.
skills/target-drug-bd-assessmentRuntime, accounts, dependencies, permissions, network behavior and task quality remain untested.
This command is recorded from the source ecosystem and resolves the registry's latest release. The fixed release shown on this page should be inspected before adoption.
clawhub install @yuanzhian-patsnap/target-drug-bd-assessmentclawhub inspect @yuanzhian-patsnap/target-drug-bd-assessment --version 1.0.0This automated, non-executing scan is bound to this release hash. It is not a safety certification and may contain false positives or false negatives.
This is registry-supplied evidence for the recorded release, not an independent SkillVetAI scan. Check the canonical source for the full report, scanner versions, scope, and current moderation state.
The catalog stores hashes and an inventory summary for change detection. It does not republish the package contents.
sha256:5f910fe98596401862c984a12cd667f1da5f8fd6de8fd4ea904472888834f66aagents/openai.yamlreferences/legacy-report-spec.mdskill-card.mdskill.manifest.jsonSKILL.md- Initial release of the target-drug-bd-assessment skill. - Provides a standardized workflow for oncology target project reports, including target validation, pipeline analysis, patent landscape, clinical data, transaction signals, and competitive profiling. - Emphasizes evidence traceability, source quality, and clear separation of observed data from strategic interpretation. - Ensures rigorous reporting standards with explicit coverage rules, output requirements, and quality checkpoints. - Designed to support project initiation, partnership evaluation, and BD due diligence—does not constitute medical, valuation, or legal advice.